Follow The Filings

KURA Kura Oncology

Kura Oncology earnings company data as of 6:18 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by KURA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KURA insider trades
  • $2.4M bought by 1 insider
  • $456K sold by 1 insider outside a trading plan
  • $2.1M sold by 5 insiders under 10b5-1 plans
  1. Kathleen Ford COO
    Planned sale
    $39K 3,668 shares at $10.75 2.5% of stake
    Traded Sep 29 Filed Sep 29
    ↗
  2. Mollie Leoni Chief Medical Officer
    Planned sale
    $310K 28,802 shares at $10.75 17% of stake
    Traded Sep 29 Filed Sep 29
    ↗
  3. Brian T. Powl Chief Commercial Officer
    Planned sale
    $250K 23,430 shares at $10.69 15% of stake
    Traded Sep 28–29 Filed Sep 29
    ↗
  4. Francis Burrows Chief Scientific Officer
    Sale
    $225K 20,726 shares at $10.83 33% of stake
    Traded Sep 24 Filed Sep 25
    ↗
  5. Troy Edward Wilson CEO
    Buy
    $1.2M 100,000 shares at $12.39 +26% to stake
    Traded Aug 24 Filed Aug 24
    ↗
  6. Brian T. Powl Chief Commercial Officer
    Planned sale
    $52K 4,345 shares at $11.89 2.5% of stake
    Traded Aug 21 Filed Aug 24
    ↗
  7. Teresa Brophy Bair Chief Legal Officer
    Planned sale
    $398K 31,487 shares at $12.63 14% of stake
    Traded Aug 19 Filed Aug 21
    ↗
  8. Troy Edward Wilson CEO
    Buy
    $1.1M 100,000 shares at $11.12 +36% to stake
    Traded Aug 17 Filed Aug 17
    ↗
  9. Mollie Leoni Chief Medical Officer
    Planned sale
    $834K 84,929 shares at $9.82 32% of stake
    Traded Jun 18 Filed Jun 22
    ↗
  10. Brian T. Powl Chief Commercial Officer
    Planned sale
    $110K 10,000 shares at $11.00 5.4% of stake
    Traded May 21 Filed May 22
    ↗
  11. Kathleen Ford COO
    Planned sale
    $20K 2,257 shares at $9.08 1.4% of stake
    Traded May 19 Filed May 20
    ↗
  12. Brian T. Powl Chief Commercial Officer
    Planned sale
    $3,122 339 shares at $9.21 0.2% of stake
    Traded May 19 Filed May 20
    ↗
  13. Teresa Brophy Bair Chief Legal Officer
    Planned sale
    $21K 2,256 shares at $9.38 1% of stake
    Traded May 18 Filed May 20
    ↗
  14. Francis Burrows Chief Scientific Officer
    Sale
    $232K 23,726 shares at $9.78 41% of stake
    Traded Dec 18, 2025 Filed Dec 19, 2025
    ↗
  15. Faheem Hasnain Director
    Planned sale
    $110K 10,000 shares at $10.98 29% of stake
    Traded Dec 9, 2025 Filed Dec 10, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 26 sales to cover taxes, 11 stock grants, and 5 option exercises.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 8.01 Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.